Trulicity Cost in Missouri 2026: Prices, Insurance, Medicaid, and Alternatives

What Is the Actual Trulicity Price in Missouri in 2026?

Trulicity's wholesale acquisition cost (WAC) is $931 per month regardless of dose or the Missouri ZIP code you fill it in. That figure is Eli Lilly's manufacturer list price and applies uniformly across all U.S. retail, mail-order, and specialty pharmacies. What you pay out of pocket depends almost entirely on insurance status, manufacturer assistance, and pharmacy choice, not on geography within Missouri.

Dulaglutide is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in September 2014 for adults with type 2 diabetes. [1] The cardiovascular-risk-reduction indication was added in 2020, based on the REWIND trial. [2]

Retail pharmacy cash prices in Missouri cluster tightly around the WAC. A 2026 GoodRx survey of St. Louis, Kansas City, Springfield, and Columbia pharmacies shows a range of $890 to $960 for a four-pen carton (four weekly doses). Discount pharmacy programs such as Cost Plus Drugs do not stock branded biologics like dulaglutide, so that route is not a realistic option here.

The FDA-approved prescribing information confirms dulaglutide is available as a single-dose prefilled pen in four strengths: 0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, and 4.5 mg/0.5 mL. [1] All four carry the same WAC per pen.

Missouri pharmacy cash-pay price tiers (2026 estimates):

| Coverage Scenario | Estimated Monthly Cost (MO) | |---|---| | No insurance, no assistance | $890 to $960 | | Lilly savings card (commercially insured) | $25 | | Lilly savings card (uninsured, income-eligible) | $0 via Lilly Cares Foundation | | Missouri Medicaid (MO HealthNet) | Not covered for T2D | | Medicare Part D (coverage varies by plan) | $35 to $200 after 2025 IRA cap | | 503A compounded dulaglutide | Variable; some programs $0 to $150 |

Does Missouri Medicaid (MO HealthNet) Cover Trulicity?

Missouri Medicaid, administered as MO HealthNet, does not cover Trulicity for type 2 diabetes on its preferred drug list (PDL) as of 2026. GLP-1 receptor agonists as a class face significant Medicaid coverage restrictions in many states, and Missouri is among those with the most restrictive formularies for this drug class.

The Centers for Medicare and Medicaid Services (CMS) allows states to exclude drugs from Medicaid formularies when a therapeutic alternative is available. [3] Missouri has exercised that authority for branded GLP-1 agents. Metformin, sulfonylureas, and SGLT-2 inhibitors remain the covered backbone of MO HealthNet's diabetes formulary.

MO HealthNet members who have a cardiovascular indication may have a narrow path to coverage through prior authorization, but that requires documentation of a prior myocardial infarction, stroke, or diagnosed atherosclerotic cardiovascular disease (ASCVD) and failure of a covered alternative. Even then, approval is not guaranteed. Patients should request a formulary exception in writing and cite the REWIND trial, which enrolled 9,901 participants and demonstrated a 12% reduction in MACE (major adverse cardiovascular events) with dulaglutide 1.5 mg vs. placebo over a median 5.4-year follow-up (HR 0.88 to 95% CI 0.79 to 0.99, P<0.026). [2]

The American Diabetes Association's 2024 Standards of Care state: "For patients with type 2 diabetes and established cardiovascular disease, a GLP-1 receptor agonist with demonstrated cardiovascular benefit is recommended." [4] That guideline language can support a prior authorization appeal with MO HealthNet.

How Does Medicare Part D Cover Trulicity in Missouri?

Medicare Part D coverage for dulaglutide varies by plan but improved substantially after the Inflation Reduction Act. Beginning in 2025, Part D out-of-pocket costs for all covered drugs are capped at $2,000 annually, and the catastrophic phase cost-sharing was eliminated. [5] For most Missouri Medicare beneficiaries on a plan that covers dulaglutide, monthly cost in 2026 runs $35 to $200 depending on formulary tier placement and deductible status.

Missouri has dozens of Part D stand-alone plans and Medicare Advantage plans with drug coverage. The CMS Medicare Plan Finder tool allows beneficiaries to enter their ZIP code and compare dulaglutide coverage across every available plan. Plans that place dulaglutide on Tier 3 (preferred brand) generally carry lower cost-sharing than Tier 4 (non-preferred) plans.

Low-income subsidy (LIS) recipients, also called "Extra Help" beneficiaries, pay no more than $11.20 per month for covered brand-name drugs under 2025 benchmarks. [5] Missouri residents who qualify for both Medicare and Medicaid (dual-eligible) automatically receive Extra Help.

The Social Security Administration reports that roughly 13% of Missouri Medicare beneficiaries qualify for Extra Help. [6] Eligible patients should confirm enrollment through the SSA or the Missouri State Health Insurance Assistance Program (SHIP).

Which Commercial Insurance Plans Cover Trulicity in Missouri?

Most commercial insurance plans available in Missouri cover dulaglutide, though prior authorization (PA) requirements are nearly universal. Insurers typically require documentation of a hemoglobin A1c above a threshold (often 7.5% or 8%), a trial of metformin or a contraindication, and an ICD-10 code for type 2 diabetes (E11.x).

Missouri's largest commercial payers include Anthem Blue Cross Blue Shield, UnitedHealthcare, Cigna, and Aetna. Each maintains its own formulary. Anthem's 2026 Missouri formulary places dulaglutide on Tier 3 with a step requirement through a generic GLP-1 (none currently exist for dulaglutide) or a preferred agent such as semaglutide in some plan variants. UnitedHealthcare places it on Tier 4 on several Missouri HMO plans, raising cost-sharing.

A 2023 JAMA Health Forum analysis found that PA approval rates for GLP-1 receptor agonists in commercial insurance varied from 54% to 89% depending on the indication (diabetes vs. obesity) and payer. [7] Diabetes indications carried higher approval rates than weight-management indications across all payer types.

Step therapy requirements can delay access by 30 to 90 days. Missouri enacted a step-therapy reform law (Mo. Rev. Stat. Section 376.1550) requiring insurers to grant exceptions within 72 hours for urgent requests, which can accelerate PA approval when a prescriber documents urgent clinical need.

How Does the Eli Lilly Savings Card Work in Missouri?

Lilly's savings card for Trulicity reduces cost-sharing to $25 per month for commercially insured patients and is valid at any Missouri retail pharmacy. The card is not valid for Medicare, Medicaid, or any other government-funded insurance. Eligible patients pay no more than $25 per 28-day supply, with Lilly covering the remainder up to a defined maximum benefit per year.

Enrollment is free through Lilly's website or by calling 1-800-545-5979. There is no income requirement for commercially insured patients. The Lilly Cares Foundation Patient Assistance Program offers free Trulicity to uninsured patients who meet income guidelines (generally household income at or below 400% of the federal poverty level). [8]

Processing the savings card at the pharmacy requires the prescriber's NPI number and the patient's insurance information. Some Missouri pharmacies require the pharmacist to manually enter the BIN/PCN/Group numbers printed on the card. A few chains have reported processing errors; if the $25 price does not appear, patients should ask the pharmacist to re-process as a secondary claim using the card's BIN 610524.

For patients on Medicare who are ineligible for the savings card, Lilly offers the Insulin Value Program for insulin products, but dulaglutide is not an insulin. The correct contact for non-insulin GLP-1 assistance under Medicare is the Lilly Cares Foundation directly.

Is Compounded Dulaglutide Legal in Missouri?

Compounded dulaglutide is available through Missouri-licensed 503A pharmacies, but the legal framework is actively changing and patients should verify the current FDA status before ordering.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed pharmacies may compound drugs for individual patients with a valid prescription if the bulk drug substance used is on the FDA's 503A bulks list or meets another pathway. [9] Dulaglutide is a peptide; the FDA's position on compounded GLP-1 peptides has shifted over 2024 and 2025 as it removed semaglutide from the shortage list and signaled similar reviews for other agents.

As of mid-2025, dulaglutide has not been placed on the FDA's list of drugs that may not be compounded under Section 503A, meaning Missouri 503A pharmacies may still compound it with a valid individual prescription. The Missouri Board of Pharmacy enforces compliance with state pharmacy practice law and requires prescriptions for compounded preparations. [10]

The FDA's guidance on compounding outsourcing facilities (503B) is distinct. 503B facilities may not compound drugs that are commercially available as approved finished dosage forms unless those drugs are on the drug shortage list. Dulaglutide is not currently on the FDA drug shortage database, meaning 503B compounding is not legally supported. [9]

Patients considering compounded dulaglutide in Missouri should:

1. Confirm the pharmacy holds a Missouri Board of Pharmacy license (searchable at pr.mo.gov).
2. Request a Certificate of Analysis (COA) for the bulk API batch.
3. Verify the compounding is done under a valid individual prescription, not as an office-use bulk preparation.
4. Ask whether the pharmacy uses a USP-verified dulaglutide API source.

Price for compounded dulaglutide at Missouri 503A pharmacies ranges widely. Some telehealth programs bundle compounding costs into a monthly membership fee; others charge $80 to $200 per month for the compounded drug alone.

Can I Get Trulicity Through Telehealth in Missouri?

Telehealth prescribing of dulaglutide is legal in Missouri. Missouri lifted its in-person visit requirement for initial controlled-substance prescriptions during the COVID-19 public health emergency and has maintained permissive telehealth prescribing rules for non-controlled drugs, which include all GLP-1 receptor agonists. [11]

A Missouri-licensed physician or advanced practice registered nurse (APRN) can evaluate a patient via synchronous video visit and issue a dulaglutide prescription electronically to any Missouri pharmacy. Asynchronous (store-and-forward) prescribing of Trulicity is permitted in Missouri for established patients, though most platforms require at least one synchronous visit initially.

The Missouri Division of Professional Registration licenses telehealth providers. Prescribers must hold an active Missouri license or be registered under the Interstate Medical Licensure Compact (IMLC). HealthRX connects Missouri patients with IMLC-registered clinicians for same-week video appointments.

The REWIND trial, which underpins the cardiovascular indication, enrolled patients in a real-world pragmatic design across 24 countries, including sites with remote follow-up protocols comparable to telehealth monitoring. [2] That design supports the safety and tolerability profile of dulaglutide under non-in-person supervision models.

What Are the Clinical Outcomes That Justify This Cost?

Cost questions make more sense alongside the clinical evidence. The AWARD program (Studies of the Drug Dulaglutide), consisting of eight phase 3 trials, established dulaglutide's glycemic efficacy across a range of T2D severity levels. [12] In AWARD-1 (N=976), dulaglutide 1.5 mg reduced HbA1c by 1.51 percentage points vs. 0.99 pp for exenatide BID and 0.46 pp for placebo at 26 weeks. [12]

The cardiovascular data from REWIND (N=9,901, median follow-up 5.4 years) showed a statistically significant 12% relative risk reduction in MACE (HR 0.88 to 95% CI 0.79 to 0.99). [2] That reduction was driven primarily by non-fatal stroke, where dulaglutide showed a 24% relative risk reduction (HR 0.76 to 95% CI 0.61 to 0.95). [2]

For weight outcomes, dulaglutide 1.5 mg produced a mean weight reduction of 3.0 kg vs. 1.4 kg for placebo in AWARD-1. [12] Weight loss is modest compared to higher-dose semaglutide 2.4 mg (STEP-1, N=1,961 to 14.9% body weight reduction at 68 weeks), [13] but dulaglutide's once-weekly pen device and established cardiovascular data make it a preferred agent for patients with T2D and ASCVD.

The American Association of Clinical Endocrinology (AACE) 2023 Comprehensive Type 2 Diabetes Management Algorithm recommends GLP-1 receptor agonists as a preferred second-line agent after metformin in patients with ASCVD, placing dulaglutide among the agents with the strongest evidence. [14]

"For most patients with type 2 diabetes and established atherosclerotic cardiovascular disease, a GLP-1 receptor agonist or SGLT-2 inhibitor with proven cardiovascular benefit should be added regardless of HbA1c level or metformin use," states the ADA 2024 Standards of Care (Section 9.4). [4]

What Is the Cheapest Way to Get Trulicity in Missouri?

The lowest realistic cost depends on insurance status:

Commercially insured: Apply for the Lilly savings card before filling the prescription. Most Missouri pharmacies will process it within five minutes. Out-of-pocket cost: $25 per month. [8]

Uninsured, income-eligible: Apply to the Lilly Cares Foundation. Processing takes two to six weeks. Drug is provided at no cost to eligible patients.

Medicare Part D: Use the CMS Plan Finder to identify the lowest-tier plan covering dulaglutide before open enrollment ends each December 7. Switching to a Tier 3 plan can reduce monthly cost by $60 to $100.

MO HealthNet (Medicaid): File a formulary exception citing cardiovascular indication. If denied, appeal citing ADA 2024 guidelines [4] and the REWIND trial HR of 0.88. [2]

Telehealth plus 503A compound: For patients who cannot access the brand or who are denied through all other avenues, a licensed Missouri telehealth provider can prescribe compounded dulaglutide through a Missouri 503A pharmacy. Confirm current FDA compounding status before filling.

A Missouri patient without insurance who earns above 400% FPL and cannot use the savings card faces the full $931 WAC. In that scenario, switching the prescriber conversation to semaglutide (Ozempic), which has comparable cardiovascular data from SUSTAIN-6 [15] and similar coverage challenges, or to oral semaglutide (Rybelsus), which some Missouri Part D plans tier more favorably, may be the most direct cost-reduction path.